Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Merck Patent Gesellschaft MIT Beschrankter Haftung Patents
Assignee:
Merck Patent Gesellschaft MIT Beschrankter Haftung
Address:
Darmstadt, DE
No. of patents:
1004
Patents:












Patent Number Title Of Patent Date Issued
RE41858 Pearlescent pigment for water-borne surface-coating systems October 26, 2010
A pearlescent pigment based on a metal oxide-coated, platelet-shaped substrate and a top layer on the metal oxide layer, where the top layer comprises silicon dioxide, at least one further metal hydroxide or metal oxide hydrate and at least one organic coupling reagent. The further m
RE41281 Liquid crystal display device April 27, 2010
The invention relates to a liquid crystal display device comprising a liquid crystal cell and at least one compensation film or a combination of polarizer and optical compensators comprising at least one compensation film, said compensation film comprising at least one layer of an is
8293891 4 (pyrrolopyridinyl)pyrimidin-2-ylamine derivatives October 23, 2012
Compounds of the formula (I), in which R.sup.1, R.sup.2, R.sup.3, R.sup.4 and R.sup.5 have the meanings indicated in claim 1, are inhibitors of cell proliferation/cell vitality and can be employed for the treatment of tumors.
8287756 Biaxial film II October 16, 2012
The invention relates to an optically biaxial film comprising an anisotropic material with uniform helically twisted structure and a reflection wavelength below 400 nm, to methods and materials for its preparation, to its use as retardation or compensation film in optical devices lik
8278454 Process for preparing tetrahydroquinoline derivatives October 2, 2012
The invention relates to a novel process for preparing enantiomerically enriched or pure tetrahydroquinoline derivatives by reacting a chiral dihydropyran-methylamine C with a aldehyde B and an aniline A in a multicomponent one pot synthesis in the presence of a protonic acid or lewi
8278394 Indenofluorene polymer based organic semiconductor materials October 2, 2012
The invention relates to polymers comprising indenofluorene units or derivatives thereof, organic semiconductor (OSC) materials comprising them, their use in electronic or electrooptical devices, and devices comprising said polymers or materials.
8278312 Imidazo 1,2-a pyrimidine derivatives for the treatment of diseases such as diabetes October 2, 2012
Novel compounds of the formula (I), in which W, T, R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6 and X.sub.7 have the meanings indicated in Patent Claim 1, are suitable as antidiabetics.
8277684 Liquid-crystal medium October 2, 2012
The invention relates to a liquid-crystalline medium of negative dielectric anisotropy based on a mixture of polar compounds, which comprises at least one compound selected from the group of the compounds of the formulae IA, IB and IC ##STR00001## in which R.sup.1A, R.sup.2A, R.sup
8273264 Liquid-crystal compounds and LC media September 25, 2012
Disclosed are novel liquid-crystal compounds, processes and intermediates for the preparation thereof, the use thereof for optical, electro-optical and electronic purposes, in particular in liquid-crystal (LC) media and LC displays, and to LC media and LC displays containing the same.
8262930 Liquid crystalline medium and liquid crystal display September 11, 2012
The instant invention relates to dielectrically positive nematic media comprising one, two or more compounds of formula I ##STR00001## one or more compounds selected from the group of formulae II and III ##STR00002## and one or more compounds selected from the group of formulae IV
8256920 Illumination unit consisting of discharge lamp, LEDs and conversion phosphors September 4, 2012
The invention relates to an illumination unit having an adjustable color location consisting of a discharge lamp as primary light source and LEDs as secondary light source and additionally a phosphor layer in the form of a phosphor screen comprising conversion phosphors. Furthermore, the
8252389 Mesogenic dimers August 28, 2012
The invention relates to novel mesogenic dimeric compounds which are especially suitable for use in birefringent films with negative optical dispersion, to novel liquid crystal (LC) formulations and polymer films comprising them, and to the use of the dimers, formulations and films in
8242107 Diazepane-acetamide derivatives as selective 11.beta.-HSD1 inhibitors August 14, 2012
The present invention relates to diazepane-acetamide derivatives of formula I as selective inhibitors of the enzyme 11-beta-hydroxysteroid dehydrogenase type 1 (11.beta.-HSD-1) and the use of such compounds for the treatment and prevention of metabolic syndrome, diabetes, insulin res
8236824 N-(pyrazole-3-yl)-benzamide derivatives as glucokinase activators August 7, 2012
Novel heterocyclic compounds of the formula I ##STR00001## in which R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7, Alk and D have the meanings indicated in claim 1, are activators of glucokinase and can be used for the prevention and/or treatment of Diabetes Typ 1 and
8236390 Liquid-crystalline medium August 7, 2012
The invention relates to a liquid-crystalline medium based on a mixture of polar compounds, characterized in that it comprises one or more compounds of the formula I ##STR00001## in which R.sup.1, X.sup.1, L.sup.1-5 have the meanings indicated in Claim 1, and to the use thereof for
8232272 Benzimidazoledihydrothiadiazinone derivatives as fructose-1,6-bisphosphatase inhibitors, and pha July 31, 2012
The present invention relates to novel benzimidazole-dihydrothiadiazinone derivatives as fructose-1,6-bisphosphatase inhibitors, to processes for the preparation thereof and to the use thereof in therapy, especially for the treatment of diabetes.
8231806 Liquid-crystalline medium and liquid-crystal display July 31, 2012
The present invention relates to dielectrically positive liquid-crystalline media comprising in each case one or more compounds of the formula I ##STR00001## in which the parameters have the respective meanings indicated in the specification, and optionally one or more further diel
8221854 Liquid crystalline medium and liquid crystal display July 17, 2012
The present invention relates to dielectrically positive liquid-crystalline media comprising a dielectrically positive component, component A, comprising a dielectrically positive compound of the formula I ##STR00001## in which the parameters have the meaning indicated in the speci
8211886 Thiadiazinone derivatives July 3, 2012
Compounds of the formula (I), ##STR00001## which are inhibitors of tyrosine kinases, in particular of Met kinase, and can be employed for the treatment of tumours.
8211513 Liquid-crystalline compounds and liquid-crystalline media July 3, 2012
The present invention relates to liquid-crystalline compounds having at least three fluorine-substituted benzene rings, a terminal trifluoromethyl group and at least one --CF.sub.2O-- bridge. The invention also relates to liquid-crystalline media prepared therewith and to liquid-crys
8202882 5-cyanothienopyridines for the treatment of tumours June 19, 2012
Novel 5-cyanothienopyridines of the formula (I), in which R.sup.1, R.sup.2 and R.sup.3 have the meanings indicated in claim 1, are inhibitors of TGF-beta receptor kinase, and can be employed, inter alia, for the treatment of tumors.
8198452 Polymorphic forms and process June 12, 2012
The invention relates to a process for the manufacture of enantiomerically enriched or pure compounds of formula I ##STR00001## wherein R.sup.1, R.sup.2, R.sup.3, R.sup.6, R.sup.7 and Q are defined as in claim 1 as well as their crystalline forms for the treatment of proliferative d
8188288 2-adamantylurea derivatives as selective 11beta-HSD1 inhibitors May 29, 2012
The present invention relates to 2-adamantylurea derivatives of formula I as selective inhibitors of the enzyme 11-beta-hydroxysteroid dehydrogenase type 1 (11.beta.-HSD1) and the use of such compounds for the treatment and prevention of metabolic syndrome, diabetes, insulin resistan
8188180 Binding agent May 29, 2012
The present invention relates to binders, to processes for the preparation thereof, and to the use thereof in formulations, surface coatings, inks and plastics.
8183279 1,3-dihydroisoindole derivatives May 22, 2012
Novel 1,3-dihydroisoindole derivatives of the formula (I), in which R.sup.1-R.sup.3 have the meanings indicated in claim 1, are HSP90 inhibitors and can be used for the preparation of a medicament for the treatment of diseases in which the inhibition, regulation and/or modulation of
8173766 Polymers derived from bis(thienocyclopenta) benzothiadiazole and their use as organic semiconduc May 8, 2012
The invention relates to conjugated polymers comprising bis(thienocyclopenta)benzothiadiazole units or derivatives thereof, to methods of their preparation, to novel monomer units used therein, to the use of the polymers in organic electronic (OE) devices, and to OE devices comprisin
8168081 Liquid-crystalline medium May 1, 2012
The invention relates to a liquid-crystalline medium based on a mixture of dielectrically negative, polar compounds which comprises at least one compound of the formula I ##STR00001## in which the parameters have the meanings indicated in claim 1, to the use thereof in an electr
8153649 3-aminoimidazo 1,2-A pyridine derivatives having an SGLT1- and SGLT2-inhibiting action for the t April 10, 2012
Novel compounds of the formula (I), in which W, T, R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5 and R.sup.6 have the meanings indicated in Patent Claim (1), are suitable as antidiabetics. ##STR00001##
8148443 Oxonium and sulfonium salts April 3, 2012
The present invention relates to oxonium salts having [(R.sup.o).sub.3O].sup.+ cations and sulfonium salts having [(R.sup.o).sub.3S].sup.+ cations, where R.sup.o denotes straight-chain or branched alkyl groups having 1-8 C atoms or phenyl which is unsubstituted or substituted by R.su
8119026 Birefringent layer with negative optical dispersion February 21, 2012
The invention relates to a birefringent layer having negative optical dispersion, a liquid crystal (LC) medium for its preparation, and the use of the birefringent layer and the LC media in optical, electrooptical, electronic, semiconducting or luminescent components or devices.
8114211 Pearlescent pigments February 14, 2012
The present invention relates to pearlescent pigments based on flake-form substrates which have at least one FeOOH layer and at least one TiO.sub.2 layer or at least one TiO.sub.2/SiO.sub.2/TiO.sub.2 layer package, and to the use thereof, inter alia, in paints, coatings, printing inks, p
8101749 Process for the preparation of onium salts with a tetrafluoroborate anion having a reduced halid January 24, 2012
The invention relates to a method for producing onium salts with tetrafluoroborate anion by reacting an onium halide with an oxonium tetrafluoroborate, sulfonium tetrafluoroborate, or triphenylcarbonium tetrafluoroborate.
8088304 Luminophores made of doped garnet for pcLEDs January 3, 2012
The invention relates to phosphors having a garnet structure of the formula I (Y.sub.a,Gd.sub.b,Lu.sub.c,Se.sub.d,Sm.sub.e,Tb.sub.f,Pr.sub.g,- Th.sub.h,Ir.sub.i,Sb.sub.j,Bi.sub.k).sub.3-x(Al.sub.l,Ga.sub.m).sub.5O.sub- .12:Ce.sub.x (I) where a+b+c+d+e+f+g+h+i+j+k=1 l+m=1 and x=0.005 to
8071593 2-oxo-3-benzylbenzoxazol-2-one derivatives and related compounds as Met kinase inhibitors for th December 6, 2011
Described are compounds which inhibit, regulate and/or modulate kinase signal transduction, for example of Met kinase. The compounds are of the formulae A1 to A148 and B1 described herein, including 2-oxobenzoxazol-3-ylmethyl]phenyl}carbamate and 2-oxooxazolo[4,5-b]pyridin-3-ylmethyl
8067625 Fluorosurfactants November 29, 2011
The present invention relates to fatty acid esters of polyols or sulfonated fatty acid esters or sulfonated fatty acid amides containing at least one group Y, where Y stands for CF.sub.3--(CH.sub.2).sub.a--O--, SF.sub.5--, CF.sub.3--(CH.sub.2).sub.a--S--, CF.sub.3CF.sub.2S--, [CF.sub
8063040 Triazabenzo[E]azulene derivatives for the treatment of tumors November 22, 2011
Novel triazabenzo[e]azulene derivatives of the formula, (I) in which R.sup.1, R.sup.2 and R.sup.3 have the meanings indicated in Claim 1, are inhibitors of TGF-beta receptor kinase and can be employed, inter alia, for the treatment of tumors.
8052963 [(4-oxo-4H-chromen-3-yl)hydroxymethyl]- or [(4-oxo-4H-chromen-3-yl)methyl]phosphonic acid deriva November 8, 2011
The present invention relates to compounds of the formula (I), where R.sup.1 to R.sup.3 each, independently of one another, denote H, hydroxyl or alkoxy having 1 to 8 C atoms, R.sup.4 denotes alkyl having 1 to 4 C atoms, H, hydroxyl or alkoxy having 1 to 8 C atoms, R.sup.5 denotes H or
8049022 Fluorosurfactants November 1, 2011
The present invention relates to fatty acid alkanolamides or polyolamides containing at least one group Y, where Y stands for CF.sub.3--(CH.sub.2).sub.a--O--, SF.sub.5--, CF.sub.3--(CH.sub.2).sub.a--S--, CF.sub.3CF.sub.2S--, [CF.sub.3--(CH.sub.2).sub.a].sub.2N-- or [CF.sub.3--(CH
8043671 Liquid-crystalline medium and liquid crystal display October 25, 2011
Disclosed are a liquid-crystalline medium based on a mixture of dielectrically negative polar compounds of each of formulae I and II ##STR00001## and the use thereof in an electro-optical display, particularly in a display with passive matrix addressing, based on a VA, ECB, PALC, FF
8021571 Chiral reactive mesogen mixture September 20, 2011
The invention relates to chiral reactive mesogen (RM) mixtures, polymer films obtained thereof, and the use of the mixtures and polymer films in optical, electrooptical or electronic components or devices, in decorative, security or cosmetic applications, especially for use in broadb
7999111 Process for the preparation of onium alkylsulfonates August 16, 2011
The invention relates to a process for the preparation of onium alkylsulfonates by reaction of an onium halide or carboxylate with a symmetrically substituted dialkyl sulfite or with an asymmetrically substituted dialkyl sulfite at temperatures of 50 to 170.degree. C.
7998540 Substituted anthracenes August 16, 2011
The invention relates to novel 9- and/or 10-substituted anthracenes, to their use in liquid crystal, light-emitting or semiconducting materials and devices, in anisotropic polymers, optical, electrooptical, decorative, security, cosmetic, diagnostic, electric, electronic, charge tran
7977343 Adenine derivatives July 12, 2011
Novel adenine derivatives of the formula (I), in which R.sup.1, R.sup.2, R.sup.3, X and Y have the meanings indicated in Claim 1, are HSP90 inhibitors and can be used for the preparation of a medicament for the treatment of diseases in which the inhibition, regulation and/or modulati
7972664 Liquid-crystalline medium July 5, 2011
Disclosed are a liquid-crystalline medium, which contains a compound of formula I ##STR00001## and the use thereof for electro-optical purposes, in particular for TN, TFT, IPS or OCB displays.
7964253 Liquid-crystalline medium and liquid-crystal display June 21, 2011
Disclosed are dielectrically positive liquid-crystalline media containing a dielectrically positive component, component A, containing one or more dielectrically positive compounds of formula I ##STR00001## and optionally a second dielectrically positive component, component B, con
7943662 Flavonoid complexes May 17, 2011
The invention relates to complexes of certain flavonoid derivatives, of the formula (I), where R.sup.1 and R.sup.2 are selected from H and OR.sup.11, where OR.sup.11 stands, independently of one another, for OH, straight-chain or branched C.sub.1- to C.sub.20-alkoxy groups, straight-
7943061 Chiral binaphthyl sulfates for use as liquid crystal materials May 17, 2011
The invention relates to chiral compounds, methods of their preparation, and to their use in optical, electrooptical, electronic, semiconducting or luminescent components or devices, and in decorative, security, cosmetic or diagnostic applications.
7928128 Use of(R)-(-) -2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane and its physiologicall April 19, 2011
(R)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane or a physiologically acceptable salt thereof is useful for treatment of adverse effects in treating Parkinson's disease.
7922934 s-Indacene and indeno[5,6-d][1,3]dioxol-derivatives and use thereof as components of liquid-crys April 12, 2011
The invention relates 1,2,3,6,7,8-hexahydro-s-indacene derivatives and 6,7-dihydro-5H-indeno[5,6-d]-1,3-dioxole derivatives, and to the use thereof as component(s) in liquid-crystalline media. In addition, the present invention relates to liquid-crystal and electro-optical display el
7922859 Laser-weldable polymers April 12, 2011
The present invention relates to laser-weldable polymers which consist of a laser-transparent part and a laser-absorbent part and can be welded to one another by means of laser light and are distinguished by the fact that the laser-absorbent part comprises, as absorber, copper hydroxide

 
 
  Recently Added Patents
Semiconductor memory apparatus
System and method for content delivery
Electronic hand-held device
Portable communication terminal, communication method and control program
Generalized AC-DC synchronous rectification techniques for single- and multi-phase systems
Display fixture for highlighting products
Cellulose acylate laminate film, method for producing cellulose acylate laminate film, polarizer and liquid crystal display device
  Randomly Featured Patents
Surgical ligaturing and animal restraining device
Printing molecular library arrays using deprotection agents solely in the vapor phase
Enchanced interference cancellation and telemetry reception in multipath environments with a single paraboic dish antenna using a focal plane array
Hybrid error correction coding to address uncorrectable errors
Substrate for electro-optical device having particular concave portions and convex portions and flat section on the surface of a base layer
Lens blind feature for motion detector
Image signal processor and method thereof
Liquid droplet generator
Van tray
Anti-curvature dental root canal shaping file